Valuation: DexCom, Inc.

Market Cap 32.69B 170B 28.68B 27.09B 24.69B 46.21B 3,133B 46.54B 324B 126B 1,601B 123B 120B 5,144B P/E 2026 *
34.7x
P/E 2027 * 29.2x
Enterprise Value 31.93B 166B 28.01B 26.46B 24.11B 45.14B 3,060B 45.46B 317B 123B 1,563B 120B 117B 5,024B EV / Sales 2026 *
6.1x
EV / Sales 2027 * 5.45x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
1 day-2.08%
1 week-3.35%
Current month-5.30%
1 month-3.66%
3 months+22.80%
6 months+36.07%
Current year+19.36%
1 week 8.94
Extreme 8.94
9.22
1 month 8.49
Extreme 8.49
9.51
Current year 5.75
Extreme 5.75
9.57
1 year 5.75
Extreme 5.75
9.57
3 years 5.75
Extreme 5.75
14.45
5 years 5.75
Extreme 5.75
18.3
10 years 5.75
Extreme 5.75
18.3
Manager TitleAgeSince
Chief Executive Officer 47 31/12/2025
Director of Finance/CFO 46 18/03/2021
Chief Tech/Sci/R&D Officer - 30/04/2024
Director TitleAgeSince
Chairman 68 29/07/2018
Director/Board Member 67 19/11/2009
Director/Board Member 47 31/12/2025
Change 5-day change 1-year change 3-year change Capi.($)
-2.08%-3.35% - - 32.69B
-0.49%-2.58%-24.63%+2.24% 175B
-0.64%-4.26%-6.52%+11.63% 113B
-0.40%-3.22%-0.57%+67.51% 58.57B
-0.67%+0.92%-0.89%-30.59% 50.07B
+0.45%+1.94%+16.04%+55.40% 49.92B
-0.14%-2.89%+30.29%-9.29% 32.69B
+0.09%+7.98% - - 30.44B
+0.29%+2.74%+42.79%-1.95% 26.07B
+2.82%+8.23%+27.57%-1.18% 23.55B
Average -0.17%+1.76%+10.51%+11.72% 62.22B
Weighted average by Cap. -0.42%+0.01%-2.98%+12.31%

Financials

2026 *2027 *
Net sales 5.23B 27.19B 4.59B 4.33B 3.95B 7.39B 501B 7.45B 51.87B 20.09B 256B 19.64B 19.21B 823B 5.8B 30.16B 5.09B 4.81B 4.38B 8.2B 556B 8.26B 57.52B 22.28B 284B 21.78B 21.31B 913B
Net income 974M 5.07B 855M 808M 736M 1.38B 93.39B 1.39B 9.66B 3.74B 47.71B 3.66B 3.58B 153B 1.15B 5.97B 1.01B 952M 868M 1.62B 110B 1.64B 11.39B 4.41B 56.26B 4.31B 4.22B 181B
Net Debt -761M -3.96B -668M -631M -575M -1.08B -72.95B -1.08B -7.55B -2.92B -37.27B -2.86B -2.8B -120B -1.06B -5.52B -931M -880M -802M -1.5B -102B -1.51B -10.53B -4.08B -51.98B -3.99B -3.9B -167B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
25/09/26 R$8.940 -2.08% 2
24/09/26 R$9.130 +0.33% 12
23/09/26 R$9.100 -1.19% 44
22/09/26 R$9.210 +1.21% 4
21/09/26 R$9.100 -1.62% 30
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
86.62USD
Average target price
94.48USD
Spread / Average Target
+9.07%

Quarterly revenue - Rate of surprise